Celprogen introduces novel pharmacological inhibitor CEP1430 for the treatment of pancreatic cancer
15 April 2015 | By Victoria White
Celprogen have developed a novel pharmacological Inhibitor, CEP1430, that is capable of inhibiting the growth of the human pancreatic cancer tumour...